Alzheimer community between disappointment and hope at CTAD conference 2016

18 December 2016 - Almost 50 million people worldwide now have dementia, and there have been no new drugs approved for the treatment of Alzheimer’s since 2003. The International Congress on Clinical Trials for Alzheimer’s Disease (CTAD) is always a good place to get an overview of what is in the pipeline and the 9th CTAD took place last week in the city of San Diego, USA. [read the full blog]